The standard of care for patients with unresectable, locally-advanced Non-Small Cell Lung Cancer (NSCLC) is definitive Radiation Therapy (RT) given with or without chemotherapy. However, outcomes with this modality are quite poor with 5-year survival estimates at 16%. A major barrier to improved outcomes is the development of Radiation-Induced Lung Injury (RILI). RILI occurs in 30% or greater of lung cancer patients and manifests on a spectrum from acute radiation Read more
